Then, we decided to examine if GBA mutations, collectively the single largest risk factor for the development of idiopathic PD [25], has an effect on any of the measured apolipoproteins, or the amount of aSN bound to lipoproteins. This evidence concerns the gene GBA1 and Parkinson disease.